002275 Guilin Sanjin Pharmaceutical

Watchlist

Pre-Opening Auction Feb 26 09:30 CST

7.88BMarket Cap19.29P/E (TTM)

Guilin Sanjin Pharmaceutical Key Stats

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/FY	-- / 2.481B	--
--	2024/FY	-- / 2.246B	--
--	2023/FY	2.172B / 2.296B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/FY-- / 2.481B--

--2024/FY-- / 2.246B--

--2023/FY2.172B / 2.296B--

--------

Unlock Free Earnings Estimates

Open Account

Guilin Sanjin: Report for the third quarter of 2024

Oct 29, 2024 12:00 ET

Guilin Sanjin: Semi-Annual Report 2024

Aug 28, 2024 12:00 ET

Guilin Sanjin: 2024 Semi-Annual Report Summary

Aug 28, 2024 12:00 ET

Guilin Sanjin Pharmaceutical: 2024 FIRST QUARTER REPORT (CORRECTED)

Apr 26, 2024 12:00 ET